Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Diseases of the Thyroid

  Free Subscription


Articles published in Anticancer Res

Retrieve available abstracts of 25 articles:
HTML format
Text format



Single Articles


    April 2019
  1. OKI T, Sugimoto T, Ogawa M, Dabanaka K, et al
    Evaluation of Follow-up Examinations Using Ultrasonography for Patients With Thyroid Nodules Initially Diagnosed as Benign.
    Anticancer Res. 2019;39:2061-2067.
    PubMed     Text format     Abstract available


    March 2019
  2. SPARTALIS E, Athanasiadis DI, Chrysikos D, Spartalis M, et al
    Histone Deacetylase Inhibitors and Anaplastic Thyroid Carcinoma.
    Anticancer Res. 2019;39:1119-1127.
    PubMed     Text format     Abstract available


    February 2019
  3. LI MU, Gu S, Mao R, Ning Y, et al
    County Median Family Income Is an Independent Prognostic Factor for Stage IV Anaplastic Thyroid Cancer.
    Anticancer Res. 2019;39:949-956.
    PubMed     Text format     Abstract available


    January 2019
  4. ZEMBSKA A, Jawiarczyk-Przybylowska A, Wojtczak B, Bolanowski M, et al
    MicroRNA Expression in the Progression and Aggressiveness of Papillary Thyroid Carcinoma.
    Anticancer Res. 2019;39:33-40.
    PubMed     Text format     Abstract available


    December 2018
  5. DOMOSLAWSKI P, Pula B, Olbromski M, Wojtczak B, et al
    Expression of Metallothionein I/II and Ki-67 Antigen in Graves' Disease.
    Anticancer Res. 2018;38:6847-6853.
    PubMed     Text format     Abstract available


  6. FUSHIMI A, Takeyama H, Manome Y
    Effect of Heparin-Protamine Treatment on Thyroid Cancer Cell Lines.
    Anticancer Res. 2018;38:6759-6762.
    PubMed     Text format     Abstract available


  7. MASSIMINO M, Tirro E, Stella S, Frasca F, et al
    Effect of Combined Epigenetic Treatments and Ectopic NIS Expression on Undifferentiated Thyroid Cancer Cells.
    Anticancer Res. 2018;38:6653-6662.
    PubMed     Text format     Abstract available


    November 2018
  8. KIM SH, Kang JG, Kim CS, Ihm SH, et al
    Evodiamine Suppresses Survival, Proliferation, Migration and Epithelial-Mesenchymal Transition of Thyroid Carcinoma Cells.
    Anticancer Res. 2018;38:6339-6352.
    PubMed     Text format     Abstract available


  9. TURBAT-HERRERA EA, Kilpatrick MJ, Chen J, Meram AT, et al
    Cystathione beta-Synthase Is Increased in Thyroid Malignancies.
    Anticancer Res. 2018;38:6085-6090.
    PubMed     Text format     Abstract available


    September 2018
  10. OWEN C, Constantinidou A, Miah AB, Thway K, et al
    Synovial Sarcoma of the Thyroid Gland, Diagnostic Pitfalls and Clinical Management.
    Anticancer Res. 2018;38:5275-5282.
    PubMed     Text format     Abstract available


    June 2018
  11. KIM YJ, Hwang HJ, Kang JG, Kim CS, et al
    Enigma Plays Roles in Survival of Thyroid Carcinoma Cells through PI3K/AKT Signaling and Survivin.
    Anticancer Res. 2018;38:3515-3525.
    PubMed     Text format     Abstract available


  12. GADDUCCI A, Pistolesi S, Guerrieri ME, Cosio S, et al
    Malignant Transformation in Mature Cystic Teratomas of the Ovary: Case Reports and Review of the Literature.
    Anticancer Res. 2018;38:3669-3675.
    PubMed     Text format     Abstract available


    May 2018
  13. SHIH YL, Huang YH, Lin KH, Chu YD, et al
    Identification of Functional Thyroid Stimulating Hormone Receptor and TSHR Gene Mutations in Hepatocellular Carcinoma.
    Anticancer Res. 2018;38:2793-2802.
    PubMed     Text format     Abstract available


    April 2018
  14. DZIGGEL L, Gebauer N, Bartscht T, Schild SE, et al
    Performance Status and Number of Metastatic Extra-cerebral Sites Predict Survival After Radiotherapy of Brain Metastases from Thyroid Cancer.
    Anticancer Res. 2018;38:2391-2394.
    PubMed     Text format     Abstract available


    March 2018
  15. NERVO A, Gallo M, Sama MT, Felicetti F, et al
    Lenvatinib in Advanced Radioiodine-refractory Thyroid Cancer: A Snapshot of Real-life Clinical Practice.
    Anticancer Res. 2018;38:1643-1649.
    PubMed     Text format     Abstract available


    January 2018
  16. ISHIBASHI N, Maebayashi T, Aizawa T, Sakaguchi M, et al
    Computed Tomography Density Change in the Thyroid Gland Before and After Radiation Therapy.
    Anticancer Res. 2018;38:417-421.
    PubMed     Text format     Abstract available


    October 2017

  17. Thyroid Cancer and Nuclear Accidents. 1st Edition.
    Anticancer Res. 2017;37:5908.
    PubMed     Text format    


  18. DO SI, Kim HS, Kim K, Lee H, et al
    Predictive Value of Sphingosine Kinase 1 Expression in Papillary Thyroid Carcinoma.
    Anticancer Res. 2017;37:5399-5405.
    PubMed     Text format     Abstract available


    September 2017
  19. WOJTCZAK B, Pula B, Gomulkiewicz A, Olbromski M, et al
    Metallothionein Isoform Expression in Benign and Malignant Thyroid Lesions.
    Anticancer Res. 2017;37:5179-5185.
    PubMed     Text format     Abstract available


  20. AMPIL F, Ellika S, Nanda A, Vora M, et al
    Long-term Survival After Stereotactic Radiosurgery of Brain Metastases: A Case Series with 10-year Follow-up.
    Anticancer Res. 2017;37:5113-5115.
    PubMed     Text format     Abstract available


    April 2017
  21. JO S, Ha TK, Han SH, Kim ME, et al
    Myricetin Induces Apoptosis of Human Anaplastic Thyroid Cancer Cells via Mitochondria Dysfunction.
    Anticancer Res. 2017;37:1705-1710.
    PubMed     Text format     Abstract available


    March 2017
  22. RUSSO M, Malandrino P, Moleti M, D'Angelo A, et al
    Thyroid Cancer in the Pediatric Age in Sicily: Influence of the Volcanic Environment.
    Anticancer Res. 2017;37:1515-1522.
    PubMed     Text format     Abstract available


    January 2017

  23. Thyroid Cancer. A Comprehensive Guide to Clinical Management. Third Edition.
    Anticancer Res. 2017;37:361.
    PubMed     Text format    


    October 2016
  24. DAMASKOS C, Valsami S, Spartalis E, Antoniou EA, et al
    Histone Deacetylase Inhibitors: A Novel Therapeutic Weapon Against Medullary Thyroid Cancer?
    Anticancer Res. 2016;36:5019-5024.
    PubMed     Text format     Abstract available


    September 2016
  25. KASMANN L, Bolm L, Janssen S, Rades D, et al
    Prognostic Factors for Survival in Patients Treated with Multimodal Therapy for Anaplastic Thyroid Cancer.
    Anticancer Res. 2016;36:4697-700.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diseases of the Thyroid is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: